Carbidopa And Levodopa Capsule, Extended Release
Product Images NDC 70710-2139
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Carbidopa And Levodopa (NDC 70710-2139). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image (10c40374 C287 4608 Bd08 5bab623bbe1d 02)
Carbidopa And Levodopa Extended-release Capsules, 23.75 mg/95 mg (10c40374 C287 4608 Bd08 5bab623bbe1d 03)
Carbidopa And Levodopa Extended-release Capsules, 36.25 mg/145 mg (10c40374 C287 4608 Bd08 5bab623bbe1d 04)
Carbidopa And Levodopa Extended-release Capsules, 48.75 mg/195 mg (10c40374 C287 4608 Bd08 5bab623bbe1d 05)
Carbidopa And Levodopa Extended-release Capsules, 61.25 mg/245 mg (10c40374 C287 4608 Bd08 5bab623bbe1d 06)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.